Press Release President Donald J. Trump announced agreements with Eli Lilly and Novo Nordisk to reduce prices of available ...
Medicare cover GLP-1s under a Trump-negotiated pricing plan starting in 2026, lowering costs for key obesity and diabetes drugs.
Eli Lilly (LLY) announced an agreement with the U.S. government to expand access to its obesity medicines and reduce patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback